MD478G2 - Method of ulcer treatment to women with hyperprolactinemia - Google Patents
Method of ulcer treatment to women with hyperprolactinemiaInfo
- Publication number
- MD478G2 MD478G2 MD96-0032A MD960032A MD478G2 MD 478 G2 MD478 G2 MD 478G2 MD 960032 A MD960032 A MD 960032A MD 478 G2 MD478 G2 MD 478G2
- Authority
- MD
- Moldova
- Prior art keywords
- days
- day
- evening
- proposed method
- method consists
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000025865 Ulcer Diseases 0.000 title abstract 2
- 231100000397 ulcer Toxicity 0.000 title abstract 2
- 208000031424 hyperprolactinemia Diseases 0.000 title 1
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 abstract 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 229940124350 antibacterial drug Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 abstract 1
- 229960002802 bromocriptine Drugs 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000008034 disappearance Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to the medicine, particularly, to the gastroenterology.The summary of the proposed method consists in the fact that in addition to the limited regimen, diet, antisecretory and antibacterial drugs bromocryptine is administered according to the following scheme: the first 3 days in the evening 1,25-2,5 mg, the 4-6th days in the morning and evening 1,25-2,5 mg, the 7-9th days 1,25-2,5 mg 3 times a day and beginning with the 10th day 2,5-3,75 mg 3 times a day till the disappearance of the ulcer chemical symptoms and normalization of prolactin high concentration in the blood stream. After that the bromocryptin doze is constantly reduced: 3 days - 1,25-2,5 mg 3 times a day, the following 2-3 days - 1,25-2,5 mg 2 times a day and the last 3 days - 1,25-2,5 mg in the evening.The technical result of the proposed method consists in the reduction of relapses amount and acceleration of gastroduodenal ulceros healing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD96-0032A MD478G2 (en) | 1996-02-20 | 1996-02-20 | Method of ulcer treatment to women with hyperprolactinemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD96-0032A MD478G2 (en) | 1996-02-20 | 1996-02-20 | Method of ulcer treatment to women with hyperprolactinemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD478F1 MD478F1 (en) | 1996-10-31 |
| MD478G2 true MD478G2 (en) | 1997-05-31 |
Family
ID=19738790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD96-0032A MD478G2 (en) | 1996-02-20 | 1996-02-20 | Method of ulcer treatment to women with hyperprolactinemia |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD478G2 (en) |
-
1996
- 1996-02-20 MD MD96-0032A patent/MD478G2/en active IP Right Grant
Non-Patent Citations (2)
| Title |
|---|
| Терапевтический архив, т. 62, № 2, 1990 г., Медицина, М., А. С. Логинов "Язвенная болезнь", с. 7-28. * |
| Терапевтический архив, т. 63, № 2,1991 г., Медицина, М., П.Я Григорьев, В.А. Исаков "Этиологические и патогенетические подходы к лечению язвенной болезни", c. 30. * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD478F1 (en) | 1996-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA37244C2 (en) | Method for treating or preventing clinical disorders curable with progesterone in female patients | |
| EP0373744A3 (en) | Use of nalmefene or naltrexone in the treatment of autoimmune diseases | |
| EP0377272A3 (en) | Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases | |
| ATE67677T1 (en) | MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE. | |
| Loiudice et al. | Treatment of acute alcoholic pancreatitis: the roles of cimetidine and nasogastric suction. | |
| GB8817015D0 (en) | Method of treatment | |
| GR3034186T3 (en) | 3,4-diarylchromans for treatment of dermatitis | |
| Sullivan et al. | Enkephalin in peripheral neuroendocrine tumours | |
| ATE102830T1 (en) | METHOD OF TREATMENT OF INTERSTITIAL BLADDER INFLAMMATION. | |
| EP1294375A4 (en) | Method of treatment of seborrheic dermatitis | |
| FR2437834A1 (en) | L-serine or glycine for treatment of cerebral deficiencies - such as mongolism and general mental debility, etc. | |
| AU573262B2 (en) | Covalently bound heparin-antithrombin iii complex | |
| MD478G2 (en) | Method of ulcer treatment to women with hyperprolactinemia | |
| EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
| Cerklewski | Influence of dietary magnesium on fluoride bioavailability in the rat | |
| US5766640A (en) | Simutaneous treatment of osteoporosis and hypertension | |
| Sweany et al. | A preliminary report on the use of para-amino salicylic acid in the treatment of pulmonary tuberculosis | |
| RU96112591A (en) | METHOD FOR TREATING CHRONIC ALCOHOLISM | |
| Mazure | Comparative efficacy of misoprostol and cimetidine in the treatment of acute duodenal ulcer: Results of major studies | |
| Subotičanec | Vitamin C status in schizophrenia | |
| Bell et al. | Conversion from troglitazone to rosiglitazone | |
| Beckingham et al. | Acute thrombocytopenia after De-Nol | |
| Mungavin et al. | Comparison of two dosage regimens of trazodone(molipaxin) in the treatment of depression. A multicentre general practice study. | |
| Johannessen et al. | 1-and 4-week cimetidine treatment for duodenal ulcer | |
| Graham et al. | Double-blind Multicenter Comparison of 1,200 mg. and 1,000 mg. Cimetidine in Hospitalized and Ambulatory Duodenal Ulcer Patients. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Granted patent for invention | ||
| IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20160220 |